Gabapentin addictive
Pro Research Analysisby 
Searched over 200M research papers for "gabapentin addictive"
Gabapentin and Its Addictive Potential: A Comprehensive Review
Introduction to Gabapentin and Its Uses
Gabapentin, a medication primarily used to treat epilepsy and neuropathic pain, has seen a significant increase in prescriptions over the past decade. Despite its therapeutic benefits, concerns have emerged regarding its potential for misuse and addiction, particularly among individuals with a history of substance use disorders (SUD) Bonnet2017Mersfelder2016Evoy2020.
Evidence of Gabapentin Misuse and Abuse
Prevalence of Misuse
Several studies have documented cases of gabapentin misuse, particularly among individuals with a history of opioid abuse. The prevalence of gabapentin misuse in the general population is relatively low, estimated at around 1.1% to 1.6% Mersfelder2016Evoy2017. However, this rate is significantly higher among individuals in drug abuse treatment centers, with reports indicating misuse rates as high as 22% Mersfelder2016Chiappini2016.
Characteristics of Misuse
Gabapentin is often misused to achieve euphoric effects, enhance the effects of opioids, or self-medicate for anxiety and withdrawal symptoms Mersfelder2016Evoy2017Chiappini2016. Misuse typically involves taking higher-than-prescribed doses, with some individuals consuming up to 8000 mg per day . The drug is also frequently used in combination with other substances, such as opioids, benzodiazepines, and alcohol, which increases the risk of adverse effects and overdose Evoy2020Chiappini2016.
Risk Factors for Gabapentin Addiction
Substance Use Disorders
The primary risk factor for gabapentin addiction is a history of substance use disorders. Most documented cases of gabapentin addiction involve individuals with previous or concurrent abuse of alcohol, cocaine, or opioids Mersfelder2016Bonnet2016Evoy2017. These individuals are more likely to misuse gabapentin to amplify the effects of other drugs or to alleviate withdrawal symptoms Bonnet2016Evoy2017.
Psychiatric Co-morbidities
Individuals with psychiatric co-morbidities, such as anxiety or depression, are also at higher risk for gabapentin misuse. These patients may use gabapentin to self-medicate for their psychiatric symptoms, leading to patterns of misuse and dependence Evoy2017Chiappini2016.
Clinical Observations and Case Reports
Behavioral Dependence
Behavioral dependence on gabapentin, characterized by craving, loss of control, and drug-seeking behavior, is relatively rare. Most cases of gabapentin dependence involve physical dependence, with symptoms such as tolerance and withdrawal being more commonly reported Bonnet2017Evoy2017Bonnet2018. There are very few documented cases of individuals seeking treatment specifically for gabapentin addiction, suggesting that its addictive potential may be lower compared to other substances Bonnet2017Bonnet2021Bonnet2018.
Withdrawal Symptoms
Withdrawal symptoms from gabapentin can occur within 12 hours to 7 days of discontinuation and may include anxiety, agitation, and physical discomfort. These symptoms are more pronounced in individuals who abruptly stop taking high doses of the medication Mersfelder2016Bonnet2016.
Conclusion
While gabapentin has therapeutic benefits, its potential for misuse and addiction, particularly among individuals with a history of substance use disorders, cannot be ignored. The evidence suggests that gabapentin misuse is a growing concern, especially when used in combination with other substances. Healthcare providers should exercise caution when prescribing gabapentin to high-risk populations and monitor for signs of misuse and dependence. Further research is needed to fully understand the addictive potential of gabapentin and to develop strategies for mitigating its risks.
Sources and full results
Most relevant research papers on this topic
How addictive are gabapentin and pregabalin? A systematic review.
Gabapentinoids show limited addictive power, with pregabalin being more addictive, and should be avoided or administered with caution in patients with substance use disorders.
DOI